Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Inflamm Res ; 54(5): 194-203, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15953991

RESUMO

OBJECTIVE: Our aim was to study how different SERMs modulate the inflammatory responses induced by lipopolysaccharide (LPS) or unmethylated CpG-oligonucleotides in mouse and rat microglial cells. MATERIALS AND METHODS: Inflammatory responses of mouse N9 microglial cells and rat primary hippocampal microglia to lipopolysaccharide (LPS) exposure were recorded by the secretion of nitric oxide (NO) and cytokine IL-6 in two models where SERM was added either 24 h before LPS addition or simultaneously or even after the LPS exposure. The responses of 17beta-estradiol, tamoxifen, raloxifene and ICI 182.780 were compared. Responses were recorded by ELISA, Northern and EMSA assays. RESULTS: SERMs but not 17beta-estradiol induced a significant, concentration-dependent anti-inflammatory response both in rat primary microglial cells and in mouse N9 microglial cells. The response was observed both in NO and IL-6 secretion as well as in total IL-6 mRNA expression. We have recently observed that histone deacetylase (HDAC) inhibitors can potentiate the LPS-induced inflammatory response. Raloxifene and tamoxifen inhibited the potentiation of LPS response induced by trichostatin A, an HDAC inhibitor, in N9 microglia. A SERM-induced anti-inflammatory response was observed in acute models where SERM was added simultaneously or even up to 6 h later than LPS exposure. In contrast, the pretreatment of N9 microglia with tamoxifen or raloxifene for 30 h before LPS exposure did not provide any protection against the LPS response. We also observed that the raloxifene-induced protection in N9 microglia was connected to a decline of LPS-induced DNA binding activity of AP-1 but not that of NF-kappaB transcription factors. CONCLUSIONS: Our results show that tamoxifen, raloxifene and ICI 182.780 induce an anti-inflammatory response in acute models of mouse and rat microglial cells. It seems that this response is not estrogen receptor-mediated but, probably, is attributable to some SERM-induced modulation of LPS-activated pro-inflammatory signalling cascades.


Assuntos
Anti-Inflamatórios/farmacologia , Inflamação/tratamento farmacológico , Microglia/patologia , Moduladores Seletivos de Receptor Estrogênico/farmacologia , Animais , Astrócitos/citologia , Northern Blotting , Proliferação de Células , Células Cultivadas , Ilhas de CpG , DNA/metabolismo , Relação Dose-Resposta a Droga , Regulação para Baixo , Ensaio de Imunoadsorção Enzimática , Estradiol/análogos & derivados , Estradiol/metabolismo , Estradiol/farmacologia , Fulvestranto , Hipocampo/citologia , Inibidores de Histona Desacetilases , Histona Desacetilases/metabolismo , Humanos , Interleucina-6/sangue , Interleucina-6/metabolismo , L-Lactato Desidrogenase/metabolismo , Lipopolissacarídeos/metabolismo , Camundongos , Microglia/metabolismo , Óxido Nítrico/metabolismo , Oligonucleotídeos/metabolismo , Ligação Proteica , RNA Mensageiro/metabolismo , Cloridrato de Raloxifeno/farmacologia , Ratos , Ratos Wistar , Tamoxifeno/farmacologia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA